![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|11|16|2053-2062
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.11, Iss.16, 2005-06, pp. : 2053-2062
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Chemokine Receptors in Chronic Obstructive Pulmonary Disease (COPD)
Current Drug Targets, Vol. 7, Iss. 6, 2006-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Chronic obstructive pulmonary disease (COPD) may represent a serious threat
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 254, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ghrelin is promising for chronic obstructive pulmonary disease (COPD)-associated cachexia
Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. :